Hydroxyapatite Crystal Deposition Disease (HADD)
WEBHydroxyapatite deposition disease (HADD) is a condition where hydroxyapatite crystals accumulate in the soft tissues surrounding joints, leading to inflammation, tenderness, and pain. It primarily affects women around the age of 45 and commonly affects the glenohumeral joint in the shoulder. Other joints such as the hip, knee, elbow, wrist, and ...
Rheumatoid Arthritis Injection Treatment Approved by FDA
WEBJune 5, 2017. Regeneron Pharmaceuticals, Inc., and Sanofi announced that the US Food and Drug Administration (FDA) has approved Kevzara (sarilumab) injection to treat adults with moderate to severe rheumatoid arthritis (RA). This treatment is recommended in patients with RA who have had an inadequate response or demonstrated intolerance to one ...
What Is the Role of Immunoglobulins in Patients With Systemic …
WEBJul 9, 2021 · Low immunoglobulin levels are not rare among patients with systemic lupus erythematosus (SLE) and may signal an increased risk for bacterial infection. 1 . In a narrative review published in Lupus, authors discussed immunoglobulin (Ig) measurements and primary and secondary causes of hypogammaglobulinemia in patients with SLE. 1. Lupus is a chronic autoimmune disease of unknown etiology that ...
What Rheumatologists Need to Know About Cancer Risk in …
WEBApr 30, 2021 · In the United States, the lifetime risk of developing cancer is 1 in 3 individuals. 1 For patients with rheumatoid arthritis (RA), this risk may be increased due to the shared etiology between cancer and RA and the immunomodulatory nature of agents commonly used in RA treatment. 2. When determining appropriate therapeutic options for …
Facet Hypertrophy | Diagnosis & Disease Information
WEBSep 12, 2022 · Etiology and Risk Factors. Spondylosis, or degeneration of the spine, is the most common cause of facet joint disease. Osteoarthritis, or degeneration that is due to natural wear and tear, is a process that involves cytokines and proteolytic enzymes. Other causes of facet hypertrophy can include trauma caused by car accidents, sports injuries, or …
Multimedia - Rheumatology Advisor
WEBEpisode 3: Patient Treatment Expectations, Success Beyond ASAS40, and Radiographic Changes in Axial Spondyloarthritis
Managing Dental and Orofacial Manifestations of Systemic Lupus ...
WEBMar 4, 2020 · Importance of a Multidisciplinary Treatment Approach. The multisystem effect of SLE and the challenges presented by dental and orofacial manifestations call for a collaborative multidisciplinary team management approach whereby rheumatologists must carefully select treatment for patients with SLE to minimize risk for oral AEs and collaborate with dental and other practitioners for medical and ...
American College of Rheumatology Releases Updated Guidelines …
WEBJun 18, 2021 · The American College of Rheumatology (ACR) recently released updated guidelines for the pharmacologic management of rheumatoid arthritis (RA). The full report has been published simultaneously in Arthritis Care & Research and Arthritis & Rheumatology.. Overall, the updated guidelines include treatment with disease-modifying antirheumatic drugs (DMARDs), including biologic DMARDs (bDMARDs) and ...
Swallowing Disorders in RA: Epidemiology and Patient Management
WEBJul 24, 2018 · Among the range of symptoms that may affect patients with rheumatoid arthritis (RA), oral, pharyngeal, and esophageal motility disorders are common. The estimated prevalence of swallowing dysfunction in this patient population is 13.1% to 33.3%. 1,2 Oropharyngeal dysphagia caused by xerostomia, masticatory impairment, and cricoarytenoid joint dysfunction has been reported. 3 In addition ...
Case Study: Systemic Lupus Erythematosus With Lupus Nephritis …
WEBFeb 7, 2019 · A 19-year-old woman presented to the hospital with complaints of progressive shortness of breath, chest pain, and lower extremity edema over the past month.
Skip to content
